{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:27:21Z","timestamp":1785562041769,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T00:00:00Z","timestamp":1280880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00198-010-1359-2","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T14:38:53Z","timestamp":1280846333000},"page":"789-796","source":"Crossref","is-referenced-by-count":46,"title":["Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study"],"prefix":"10.1007","volume":"22","author":[{"name":"the CaMos Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-A.","family":"Fraser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. P.","family":"Olszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Anastassiades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Goltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,4]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382","journal-title":"Bone"},{"key":"1359_CR2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","volume":"114","author":"PD Ross","year":"1991","unstructured":"Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919\u2013923","journal-title":"Ann Intern Med"},{"key":"1359_CR3","first-page":"S1","volume":"167","author":"JP Brown","year":"2002","unstructured":"Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167:S1\u2013S34","journal-title":"CMAJ"},{"key":"1359_CR4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jocd.2007.01.001","volume":"10","author":"K Siminoski","year":"2007","unstructured":"Siminoski K, Leslie WD, Frame H, Hodsman A, Josse RG, Khan A, Lentle BC, Levesque J, Lyons DJ, Tarulli G, Brown JP (2007) Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom 10:120\u2013123","journal-title":"J Clin Densitom"},{"key":"1359_CR5","unstructured":"The National Osteoporosis Foundation (NOF) Clinician's Guide to prevention and treatment of osteoporosis 2008. National Osteoporosis Foundation, Washington, DC"},{"key":"1359_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","volume":"9","author":"AACE Osteoporosis Task Force","year":"2003","unstructured":"AACE Osteoporosis Task Force (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9:544\u2013564","journal-title":"Endocr Pract"},{"key":"1359_CR7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00198-008-0743-7","volume":"20","author":"A Papaioannou","year":"2009","unstructured":"Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP et al (2009) The impact of incident fractures on health-related quality of life: 5\u00a0years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20:703\u2013714","journal-title":"Osteoporos Int"},{"key":"1359_CR8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","volume":"159","author":"KM Kado","year":"1999","unstructured":"Kado KM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR (1999) Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporostic Fractures Research Group. Arch Intern Med 159:1215\u20131220","journal-title":"Arch Intern Med"},{"key":"1359_CR9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11914-003-0011-x","volume":"1","author":"RW Keen","year":"2003","unstructured":"Keen RW (2003) Burden of osteoporosis and fractures. Curr Osteoporos Rep 1:66\u201370","journal-title":"Curr Osteoporos Rep"},{"key":"1359_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.081720","volume":"181","author":"G Ioannidis","year":"2009","unstructured":"Ioannidis G, Papaioannou A, Hopman WM et al (2009) Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 181:265\u2013271","journal-title":"CMAJ"},{"key":"1359_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1532-5415.2000.tb02641.x","volume":"48","author":"KE Ensrud","year":"2000","unstructured":"Ensrud KE, Thompson DE, Cauley JA et al (2000) Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48:241\u2013249","journal-title":"J Am Geriatr Soc"},{"key":"1359_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00198-007-0426-9","volume":"19","author":"L Bessette","year":"2008","unstructured":"Bessette L, Ste-Marie LG, Jean S et al (2008) The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 19:79\u201386","journal-title":"Osteoporos Int"},{"key":"1359_CR13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"1359_CR14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508\u2013516","journal-title":"Endocr Rev"},{"key":"1359_CR15","first-page":"CD001155","volume":"23","author":"GA Wells","year":"2002","unstructured":"Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2002) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 23:CD001155","journal-title":"Cochrane Database Syst Rev"},{"key":"1359_CR16","first-page":"CD003376","volume":"4","author":"A Cranney","year":"2001","unstructured":"Cranney A, Welch V, Adachi JD, Guyatt G, Krolicki N, Griffith L, Shea B, Tugwell P, Wells G (2001) Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database Syst Rev 4:CD003376","journal-title":"Cochrane Database Syst Rev"},{"key":"1359_CR17","doi-asserted-by":"crossref","unstructured":"Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G (2003) Risedronate for the prevention and treatment of postmenopausal osteoporosis. 4:CD004523","DOI":"10.1002\/14651858.CD004523"},{"key":"1359_CR18","first-page":"819","volume":"163","author":"EE Hajcsar","year":"2000","unstructured":"Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fracture. Can Med Assoc J 163:819\u2013822","journal-title":"Can Med Assoc J"},{"key":"1359_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2474-5-11","volume":"5","author":"A Papaioannou","year":"2004","unstructured":"Papaioannou A, Giangregorio L, Kvern B et al (2004) The osteoporosis care gap in Canada. BMC Musculoskelet Disord 5:11","journal-title":"BMC Musculoskelet Disord"},{"key":"1359_CR20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semarthrit.2005.11.001","volume":"35","author":"L Giangregorio","year":"2006","unstructured":"Giangregorio L, Papaioanou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility Fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293\u2013305","journal-title":"Semin Arthritis Rheum"},{"key":"1359_CR21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-007-0483-0","volume":"19","author":"A Papaioannou","year":"2008","unstructured":"Papaioannou A, Kennedy CC, Ioannidis G et al (2008) The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 19:581\u2013587","journal-title":"Osteoporos Int"},{"key":"1359_CR22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1017\/S0714980800009934","volume":"18","author":"N Kreiger","year":"1999","unstructured":"Kreiger N, Tenenhouse A, Joseph L, Mackenzie T, Poliquin S, Brown JP, Prior JC, Rittmaster RS (1999) The Canadian Multicentre Osteoporosis Study (CaMos): background, rationale, methods. Can J Aging 18:376\u2013387","journal-title":"Can J Aging"},{"key":"1359_CR23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00198-009-0966-2","volume":"21","author":"E Kingwell","year":"2010","unstructured":"Kingwell E, Prior JC, Ratner PA, Kennedy SM (2010) Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians. Osteoporos Int 21:307\u2013319","journal-title":"Osteoporos Int"},{"key":"1359_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"K-Y Liang","year":"1986","unstructured":"Liang K-Y, Zeger SL (1986) Longitudinal data analysis using generalized linearmodels. Biometrika 73:13\u201322","journal-title":"Biometrika"},{"key":"1359_CR25","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2106\/00004623-200312000-00005","volume":"85","author":"AC Feldstein","year":"2003","unstructured":"Feldstein AC, Nichols GA, Elmer PJ, Smith DH, Aickin M, Herson M (2003) Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am 85:2294\u20132302","journal-title":"J Bone Joint Surg Am"},{"key":"1359_CR26","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.163.18.2165","volume":"163","author":"A Feldstein","year":"2003","unstructured":"Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T (2003) Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures. A gap in evidence-based practice guideline implementation. Arch Intern Med 163:2165\u20132172","journal-title":"Arch Intern Med"},{"key":"1359_CR27","first-page":"1270","volume":"54","author":"CJ Metge","year":"2008","unstructured":"Metge CJ, Leslie WD, Manness LJ, Yogendran M, Yuen CK, Kvern B, the Maximizing Osteoporosis Management in Manitoba Steering Committee (2008) Postfracture care for older women. Gaps between optimal care and actual care. Can Fam Physician 54:1270\u20131276","journal-title":"Can Fam Physician"},{"key":"1359_CR28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2106\/00004623-200208000-00008","volume":"84A","author":"MJ Gardner","year":"2002","unstructured":"Gardner MJ, Flik KR, Mooar P, Lane JM (2002) Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Jt Surg 84A:1342\u20131348","journal-title":"J Bone Jt Surg"},{"key":"1359_CR29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"1359_CR30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsmen PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"1359_CR31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","volume":"332","author":"SR Cummings","year":"1995","unstructured":"Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767\u2013773","journal-title":"N Engl J Med"},{"key":"1359_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S8756-3282(99)00202-1","volume":"25","author":"MC Nevitt","year":"1999","unstructured":"Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE (1999) Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group. Bone 25:613\u2013619","journal-title":"Bone"},{"key":"1359_CR33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1359\/jbmr.081103","volume":"24","author":"P Chen","year":"2009","unstructured":"Chen P, Krege JH, Adachi JD, Prior JC, Tenenhouse A, Brown JP, Papadimitropoulos M, Kreiger N, Olszynski WP, Josse RG, Goltzman D (2009) Vertebral fracture status and the World Health Organization (WHO) risk factors for predicting osteoporotic fracture risk. J Bone Miner Res 24:495\u2013502","journal-title":"J Bone Miner Res"},{"key":"1359_CR34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079903125003125","volume":"20","author":"C Roux","year":"2004","unstructured":"Roux C, Seeman E, Eastell R, Adachi J, Jackson RD, Felsenberg D, Songcharoen S, Rizzoli R, Di Munno O, Horlait S, Valent D, Watts NB (2004) Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 20:433\u2013493","journal-title":"Curr Med Res Opin"},{"key":"1359_CR35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-003-0042-4","volume":"74","author":"JT Harrington","year":"2004","unstructured":"Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, Barton I, Boonen S (2004) Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int 74:129\u2013135","journal-title":"Calcif Tissue Int"},{"key":"1359_CR36","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"1359_CR37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1503\/cmaj.070234","volume":"177","author":"A Cranney","year":"2007","unstructured":"Cranney A, Jamal SA, Tsang TF, Josse RG, Leslie WD (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177:575\u2013580","journal-title":"CMAJ"},{"key":"1359_CR38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","volume":"17","author":"The North American Menopause Society","year":"2010","unstructured":"The North American Menopause Society (2010) Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 17:25\u201354","journal-title":"Menopause"},{"key":"1359_CR39","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.1998.13.8.1337","volume":"13","author":"KM Sanders","year":"1998","unstructured":"Sanders KM, Pasco JA, Ugoni AM, Nicholson GC, Seeman E, Martin TJ, Skoric B, Panahi S, Kotowicz MA (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13:1337\u20131342","journal-title":"J Bone Miner Res"},{"key":"1359_CR40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00198-004-1675-5","volume":"15","author":"V Elliot-Gibson","year":"2004","unstructured":"Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767\u2013778","journal-title":"Osteoporos Int"},{"key":"1359_CR41","unstructured":"Osteoporosis Canada (2007). Provincial access to etidronate, alendronate, risedronate, calcitonin, raloxifene and teriparatide. Retrieved November 22, 2009 from http:\/\/www.osteoporosis.ca\/index.php\/ci_id\/5521\/la_id\/1.htm"},{"issue":"1","key":"1359_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3148\/70.1.2009.21","volume":"70","author":"S Poliquin","year":"2009","unstructured":"Poliquin S, Joseph L, Gray-Donald K (2009) Calcium and vitamin D intakes in an adult Canadian population. Can J Diet Pract Res 70(1):21\u201327","journal-title":"Can J Diet Pract Res"},{"key":"1359_CR43","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","volume":"282","author":"ST Harris","year":"1999","unstructured":"Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282:1344\u20131352","journal-title":"JAMA"},{"key":"1359_CR44","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jc.85.11.4118","volume":"85","author":"DM Black","year":"2000","unstructured":"Black DM, Thompson DE, Bauer DC et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. FIT Research Group. J Clin Endocrinol Metab 85:4118\u20134124","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1359-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1359-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1359-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:44:32Z","timestamp":1559367872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1359-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,4]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1359-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,4]]}}}